Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Q Therapeutics Inc.
DescriptionHuman glial restricted progenitor cells and their progeny
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentIND
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation U.S. - Orphan Drug (Treat amyotrophic lateral sclerosis (ALS))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today